|
⚲
|
| Keyboard |
| Matthew Rieke | |
|---|---|
| Firm | |
| Address | c/o Tarsa Therapeutics, Inc 8 Penn Center, 1628 Jfk Blvd, Ste 1400 Philadelphia, PA 19103-2124 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Tarsa Therapeutics Inc | 021-175388 | Director | 13.8 M of 28.0 M |
||
| Tarsa Therapeutics Inc | 021-148747 | Director | 15.5 M of 24.5 M |
||
| Nitric Biotherapeutics Inc | 021-144732 | Director | 1.8 M of 6.0 M |
||
| Tearscience Inc | 021-142113 | Director | 39.6 M of 44.6 M |
||
| Neotropix Inc | 021-71701 | Director | 1.4 M of 3.0 M |
||
| Nitric Biotherapeutics Inc | 021-129661 | Director | 1.7 M of 2.2 M |
||